rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGGACACAAATGGCTACACCTTCGGTTCG	CASSVGDTNGYTF	In	VDJ	1	23	0.0021435228331780055	0.0024709926944563817	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	6	6	0	3	23	-1	45	39	48			01,02										Vb 1	CASSVGDTNGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTACACCAGGGAATTGATCCCTTGGACATTCAGTACTTCGGCGCC	CASSLHQGIDPLDIQYF	In	VDJ	1	33	0.003075489282385834	0.0035453373442200257	51	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	4	3	8	6	14	23	35	46	41	60			01,02										Vb 1	CASSLHQGIDPLDIQYF+TCRBV09-01+TCRBJ02-04	TCRBV09-01	TCRBD01-01*01	TCRBJ02-04*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGATTGGGACAGGGCTTACTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	32	0.0029822926374650513		41	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	0	3	5	3	6	29	37	49	40	55													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGGGCAAGACGGCGAGCAGTACTTCGGGCCG	CASSQDGQDGEQYF	In	VDJ	1	42	0.00391425908667288	0.0045122475290073055	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	8	0	6	1	7	29	46	51	47	58													Vb 16	CASSQDGQDGEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGACACCTTCTATGGCTACACCTTCGGTTCG	CASSQDTFYGYTF	In	VDJ	1	57	0.005312208760484623	0.006123764503652772	39	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	0	3	7	4	1	3	29	46	49	47	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQDTFYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAAACAGCGCTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQETALNTGELFF	In	VDJ	1	92	0.008574091332712022	0.009883970777825527	48	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-02	01	0	3	5	1	1	4	29	46	51	47	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQETALNTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01		TCRBJ02-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAACGGGCTGGGACCCGACCTTTTTTTGGACAA	CASSQERAGTRPFF	In	VDJ	2	97	0.009040074557315937	0.010421143102707349	42	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-01	01	0	0	7	17	7	10	29	46	58	53	68				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQERAGTRPFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01		TCRBJ01-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTATATAGCGGGGGGCTCACAGATACGCAGTATTTTGGCCCA	CASSVYSGGLTDTQYF	In	VDJ	1	21	0.00195712954333644	0.0022561237645036527	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	5	1	2	5	2	24	36	51	41	53														CASSVYSGGLTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCCCGCGGAGGGAGTGGCACAGATACGCAGTATTTTGGCCCA	CASSSRGGSGTDTQYF	In	VDJ	1	23	0.0021435228331780055	0.0024709926944563817	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	0	1	6	4	24	36	48	42	52														CASSSRGGSGTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCCCCGACAGGGGTCCTTCTACAATGAGCAGTTCTTCGGGCCA	CASSPRQGSFYNEQFF	In	VDJ	1	27	0.002516309412861137	0.0029007305543618392	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	2	3	5	5	24	35	48	40	53														CASSPRQGSFYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTGGAGTTCTAGCGGGAGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	33	0.003075489282385834		50	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	4	1	1	7	0	24	36	-1	43	54														X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGGGGACGGCTCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSGDGSGTGELFF	In	VDJ	1	51	0.004753028890959925	0.005479157713794585	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-02	01	6	0	7	4	2	8	24	35	42	37	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGDGSGTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01		TCRBJ02-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGCAGAATGTTGGAAGTCTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	59	0.0054986020503261885		56	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	1	8	4	10	16	24	35	48	45	64				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGAGCGGGGGTGGAGACCCAGTACTTCGGGCCA	CASSVGAGVETQYF	In	VDJ	1	60	0.005591798695246971	0.006446067898581865	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	6	2	5	5	2	24	36	49	41	51														CASSVGAGVETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACGCTTTCCGACACCCAAGAGACCCAGTACTTCGGGCCA	CASTLSDTQETQYF	In	VDJ	1	63	0.00587138863000932	0.006768371293510958	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	2	6	1	11	1	24	31	46	42	47														CASTLSDTQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGAGGCAAGGGTAGGGGAGACCCAGTACTTCGGGCCA	CASSEARVGETQYF	In	VDJ	1	70	0.0065237651444548	0.007520412548345509	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-05	01	6	5	3	5	7	5	24	35	46	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEARVGETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01		TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCAAGTAGGGCTAGCGGGAGGGCCTGGGGAGACCCAGTACTTCGGGCCA	CASSQVGLAGGPGETQYF	In	VDJ	1	27	0.002516309412861137	0.0029007305543618392	54	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	4	0	5	9	6	19	31	52	40	58														CASSQVGLAGGPGETQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACAGATTAATGAAAAACTGTTTTTTGGCAGT	CAWSVQINEKLFF	In	VDJ	1	58	0.005405405405405406	0.006231198968629136	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	3	5	4	0	2	26	-1	44	40	46			unresolved										Vb 20	CAWSVQINEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-04*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTTGGACTAGCGCGAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSQVGLARDTGELFF	In	VDJ	1	26	0.002423112767940354	0.002793296089385475	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	1	6	3	2	4	23	39	50	41	54						01,02								CASSQVGLARDTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD02-01	TCRBJ02-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGACAGGAGAACTAACTATGGCTACACCTTCGGTTCG	CASSQDRRTNYGYTF	In	VDJ	1	28	0.00260950605778192	0.0030081650193382035	45	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-02	01	0	4	4	0	0	4	23	-1	44	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRRTNYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01		TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGACAGGGGGCCGACCTTCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	84	0.00782851817334576		52	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	1	0	2	0	7	23	-1	50	39	57														X+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTTTTGGGACAGGGATTTCGGAATGAGCAGTTCTTCGGGCCA	CASSQVLGQGFRNEQFF	In	VDJ	2	106	0.009878844361602983	0.011388053287494627	51	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	0	3	7	4	7	23	39	52	43	59														CASSQVLGQGFRNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCGGGACAGGGGGGGAATACGCAGTATTTTGGCCCA	CASSPGQGGNTQYF	In	VDJ	1	33	0.003075489282385834	0.0035453373442200257	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	1	7	3	3	25	36	50	39	53													Vb 3	CASSPGQGGNTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCGACTAGCGCCCTCGGGGAGCTGTTTTTTGGAGAA	CASSPTSALGELFF	In	VDJ	1	59	0.0054986020503261885	0.0063386334336055	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	2	6	7	3	4	25	36	47	39	51						01,02							Vb 3	CASSPTSALGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGGACAGGGGGCTTGCAGCCCCAGCATTTTGGTGAT	CASSRTGGLQPQHF	In	VDJ	1	73	0.006803355079217148	0.007842715943274603	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	0	7	1	3	25	37	49	38	52													Vb 3	CASSRTGGLQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGAGCTCGGACAGGGAAAACGTGAAAAACTGTTTTTTGGCAGT	CASSELGQGKREKLFF	In	VDJ	2	122	0.011369990680335508	0.01310700472711646	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	3	7	6	6	25	37	51	43	57													Vb 3	CASSELGQGKREKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATGTCTGTGCTAGCCGAAGACGGACAGGGGGAAAGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	34	0.003168685927306617		49	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	12	1	1	4	11	4	18	23	44	34	48														X+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTACGATGACAGGGCGAGTGGCTACACCTTCGGTTCG	CASSYDDRASGYTF	In	VDJ	1	19	0.0017707362534948741	0.0020412548345509238	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	7	6	4	23	35	48	41	52													Vb 12	CASSYDDRASGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTACCGAGCGGGGGGGCCCAATGAGCAGTTCTTCGGGCCA	CASSYRAGGPNEQFF	In	VDJ	1	23	0.0021435228331780055	0.0024709926944563817	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	0	6	5	2	23	35	50	40	52													Vb 12	CASSYRAGGPNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAGTCAAAGGGAACTAATAAAAAACTGTTTTTTGGCAGT	CAISESKGTNKKLFF	In	VDJ	1	44	0.004100652376514445	0.004727116458960034	45	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-04	01	0	0	8	9	3	7	24	41	48	44	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESKGTNKKLFF+TCRBV10-03+TCRBJ01-04	TCRBV10-03*01		TCRBJ01-04*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTCCGACAGGGCTTACACTGAAGCTTTCTTTGGACAA	CASSDRAYTEAFF	In	VDJ	1	22	0.0020503261882572226	0.002363558229480017	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	2	3	3	4	3	27	35	46	39	49			01,02										Vb 17	CASSDRAYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCGGGACAGTCCAAGAGACCCAGTACTTCGGGCCA	CASSIGGTVQETQYF	In	VDJ	1	25	0.002329916123019571	0.0026858616244091102	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	5	1	2	1	27	43	52	45	53			01,02										Vb 17	CASSIGGTVQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGATTCGGCACAGATACGCAGTATTTTGGCCCA	CASRFGTDTQYF	In	VDJ	1	27	0.002516309412861137	0.0029007305543618392	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	8	6	1	3	0	27	38	-1	41	43			01,02			01,02							Vb 17	CASRFGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACAGGGATTAAGCACAGATACGCAGTATTTTGGCCCA	CASRQGLSTDTQYF	In	VDJ	1	41	0.0038210624417520968	0.004404813064030941	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	3	0	0	4	27	-1	44	38	48			01,02										Vb 17	CASRQGLSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAACAGGGGGCCTGTGGCTACACCTTCGGTTCG	CASSQQGACGYTF	In	VDJ	1	44	0.004100652376514445	0.004727116458960034	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	0	7	2	3	27	39	50	41	53			01,02										Vb 17	CASSQQGACGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCCACGGACAGACGATTTACGAGCAGTACTTCGGGCCG	CASSIGHGQTIYEQYF	In	VDJ	1	54	0.005032618825722274	0.0058014611087236784	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	5	4	5	6	27	43	54	48	60			01,02										Vb 17	CASSIGHGQTIYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTCGGTTCAAGGGGATTCACCCCTCCACTTTGGGAAC	CASSVQGDSPLHF	In	VDJ	1	56	0.00521901211556384	0.006016330038676407	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	9	5	2	8	9	0	27	35	-1	44	49			01,02										Vb 17	CASSVQGDSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCGACAGGTGGCTCCTACGAGCAGTACTTCGGGCCG	CASSATGGSYEQYF	In	VDJ	1	72	0.006710158434296365	0.007735281478298238	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	4	0	2	3	27	39	47	41	50			01,02										Vb 17	CASSATGGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGACAGTAGGGAGACCCAGTACTTCGGGCCA	CASSRDSRETQYF	In	VDJ	1	74	0.006896551724137931	0.007950150408250967	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	5	5	0	4	27	-1	47	40	51			01,02										Vb 17	CASSRDSRETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGTCAGGGGGGAAATGAGCAGTTCTTCGGGCCA	CASRQGGNEQFF	In	VDJ	1	82	0.0076421248835041936	0.008809626128061882	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	4	1	7	3	2	27	36	46	39	48			01,02										Vb 17	CASRQGGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGTTAGTAGTTATGAGACAGGGAGGCACACCGGGGAGCTGTTTTTTGGAGAA	CVSSYETGRHTGELFF	In	VDJ	2	117	0.010904007455731593	0.012569832402234637	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	3	3	5	4	27	39	51	44	55			01,02										Vb 17	CVSSYETGRHTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCAGGGGAATCGTGCCGGGGAGCTGTTTTTTGGAGAA	CASSMQGNRAGELFF	In	VDJ	2	121	0.011276794035414725	0.012999570262140095	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	2	6	1	7	27	41	48	42	55			01,02										Vb 17	CASSMQGNRAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATAGGTCTGATGGCTACACCTTCGGTTCG		Out	VDJ	1	47	0.004380242311276794		37	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-02	01	0	0	10	6	0	4	23	-1	42	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01		TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCCCCCAGGGTCCCCAAGAGACCCAGTACTTCGGGCCA	CSVVPQGPQETQYF	In	VDJ	1	19	0.0017707362534948741	0.0020412548345509238	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	3	1	5	3	25	35	45	40	48													Vb 4	CSVVPQGPQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGCGGGAGTGGTGTCGATGAGCAGTTCTTCGGGCCA	CSVSGSGVDEQFF	In	VDJ	1	24	0.0022367194780987883	0.002578427159432746	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	2	8	0	8	25	-1	42	34	50													Vb 4	CSVSGSGVDEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCACCGGGACAGGGGGCAGGCACGAGCAGTACTTCGGGCCG	CSATGTGGRHEQYF	In	VDJ	1	41	0.0038210624417520968	0.004404813064030941	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	0	5	5	4	25	32	49	37	53													Vb 4	CSATGTGGRHEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAAACTCCCTATCGTCGGGGAACACTGAAGCTTTCTTTGGACAA	CSVENSLSSGNTEAFF	In	VDJ	1	65	0.0060577819198508855	0.006983240223463687	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	8	4	1	13	0	25	37	-1	50	54						01,02							Vb 4	CSVENSLSSGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACTCGACAGGGAACAACTACGAGCAGTACTTCGGGCCG	CSARDSTGNNYEQYF	In	VDJ	1	19	0.0017707362534948741	0.0020412548345509238	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	3	3	3	5	26	40	50	43	55		TCRBV20-01,TCRBV20-or09_02												CSARDSTGNNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAAGGGGGCGGGGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	19	0.0017707362534948741		43	TCRBV12						TCRBJ02	TCRBJ02-05	01	2	5	0	4	0	5	22	-1	44	37	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCCGACGGGGGAGGGACAGATACGCAGTATTTTGGCCCA	CASSSDGGGTDTQYF	In	VDJ	1	19	0.0017707362534948741	0.0020412548345509238	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	9	0	3	7	0	18	31	-1	38	45	TCRBV05,TCRBV11													CASSSDGGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AACCCAGGGACTCRGCYGTGTATKTYTGTGCCAGCAGAACACCCACCGGGACAGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	0.001863932898415657		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	0	10	2	26	37	54	47	56	TCRBV11,TCRBV12													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTAAACGGGCGGGAGGGGTTAGAGACCCAGTACTTCGGGCCA	CSALNGREGLETQYF	In	VDJ	1	20	0.001863932898415657	0.0021486892995272885	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	7	0	4	9	3	26	34	52	43	55		TCRBV20-01,TCRBV20-or09_02												CSALNGREGLETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACCTTTAGTCAGGGGGGGCTGGGGCTACACCTTCGGTTCG	CSAPLVRGGWGYTF	In	VDJ	1	21	0.00195712954333644	0.0022561237645036527	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	4	1	8	9	6	26	34	50	43	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPLVRGGWGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCAAGATTATAGGGGGGACTATGGCTACACCTTCGGTTCG	CASSQDYRGDYGYTF	In	VDJ	1	21	0.00195712954333644	0.0022561237645036527	45							TCRBJ01	TCRBJ01-02	01	0	5	1	3	4	1	18	35	45	39	46	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDYRGDYGYTF+X+TCRBJ01-02			TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCGGGATCAGGAAACACTGAAGCTTTCTTTGGACAA	CASSPGSGNTEAFF	In	VDJ	1	22	0.0020503261882572226	0.002363558229480017	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	3	2	1	6	24	36	42	37	48	TCRBV09,TCRBV21													CASSPGSGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
TMSCTCCCARACATCTGTGTACTTCTGTGCCAGCAGTTACGGCACAGATACGCAGTATTTTGGCCCA	CASSYGTDTQYF	In	VJ	1	22	0.0020503261882572226	0.002363558229480017	36	TCRBV06						TCRBJ02	TCRBJ02-03	01	2	0	0	1	0	1	25	-1	40	-1	41		TCRBV06-02,TCRBV06-03												CASSYGTDTQYF+TCRBV06-X+TCRBJ02-03	TCRBV06		TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCACCTGACAGCTACGAGCAGTACTTCGGGCCG	CSARSPDSYEQYF	In	VDJ	1	23	0.0021435228331780055	0.0024709926944563817	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	5	3	6	0	26	38	-1	44	49		TCRBV20-01,TCRBV20-or09_02												CSARSPDSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTGAAGGTAGCGGGAGCGCAGATACGCAGTATTTTGGCCCA	CASSEGSGSADTQYF	In	VDJ	1	23	0.0021435228331780055	0.0024709926944563817	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	2	4	5	2	22	34	48	39	50		TCRBV12-03,TCRBV12-04												CASSEGSGSADTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
MSCWMCCAGACAKCTSTKTACTTCTGTGCCAGCTTCGGGTCTGCCTACGAGCAGTACTTCGGGCCG	CASFGSAYEQYF	In	VDJ	1	23	0.0021435228331780055	0.0024709926944563817	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	11	8	4	2	4	4	24	31	39	35	43	TCRBV10,TCRBV24					01,02								CASFGSAYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGAACTACGAGAGGCTACACCTTCGGTTCG	CSARTTRGYTF	In	VDJ	1	24	0.0022367194780987883	0.002578427159432746	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	3	9	8	0	5	26	-1	42	38	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSARTTRGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCAGATCAGGAGACCCAGTACTTCGGGCCA	CASSPDQETQYF	In	VDJ	1	25	0.002329916123019571	0.0026858616244091102	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	5	5	1	0	23	40	-1	41	44	TCRBV01,TCRBV04													CASSPDQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGAGACTAGCGGGGGAGAGACCCAGTACTTCGGGCCA	CASSLETSGGETQYF	In	VDJ	1	25	0.002329916123019571	0.0026858616244091102	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	2	2	4	3	0	18	32	-1	35	47	TCRBV05,TCRBV11													CASSLETSGGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATTGGACAGGGCCACAGATACGCAGTATTTTGGCCCA	CASSLLDRATDTQYF	In	VDJ	1	26	0.002423112767940354	0.002793296089385475	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	1	3	2	2	1	26	41	51	43	52		TCRBV12-03,TCRBV12-04												CASSLLDRATDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGAGACTGGCGAGACCCAGTACTTCGGGCCA	CSASETGETQYF	In	VDJ	1	27	0.002516309412861137	0.0029007305543618392	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	2	10	5	3	3	26	37	44	40	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSASETGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGATCAGGTACTAGGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	0.002516309412861137		46	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	3	8	3	7	2	18	34	46	41	48	TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGATGACGCACGGCGGGAGCAGTTCTTCGGGCCA	CASSLDDARREQFF	In	VDJ	1	27	0.002516309412861137	0.0029007305543618392	42	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	7	5	10	12	0	19	33	-1	45	49		TCRBV05-06,TCRBV05-07				01,02								CASSLDDARREQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCCTTCGTGGATGAGCAGTTCTTCGGGCCA	CSARPFVDEQFF	In	VDJ	1	28	0.00260950605778192	0.0030081650193382035	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	0	10	8	9	0	26	37	-1	46	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPFVDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAATCGAAGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASNRRGNTGELFF	In	VDJ	1	28	0.00260950605778192	0.0030081650193382035	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	11	5	2	1	8	0	24	31	-1	39	44	TCRBV06,TCRBV24													CASNRRGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTTCTTTGTCCGGGGGGTCGGTGACCCAGTACTTCGGGCCA	CASSSLSGGSVTQYF	In	VDJ	1	29	0.002702702702702703	0.003115599484314568	45	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	8	1	7	7	5	24	37	51	44	56		TCRBV06-05,TCRBV06-06												CASSSLSGGSVTQYF+TCRBV06-X+TCRBJ02-05	TCRBV06	TCRBD02-01*01	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCAACAGGGTAACTATGGCTACACCTTCGGTTCG	CASSQQGNYGYTF	In	VDJ	1	30	0.0027958993476234857	0.0032230339492909325	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	1	0	0	26	-1	-1	41	46		TCRBV03-01,TCRBV03-02												CASSQQGNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCGGGGACTAGCGGGAGTTACCGGGGAGCTGTTTTTTGGAGAA	CASSRGLAGVTGELFF	In	VDJ	1	30	0.0027958993476234857	0.0032230339492909325	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	0	2	5	3	2	26	37	54	40	56		TCRBV03-01,TCRBV03-02												CASSRGLAGVTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCCAGGGCTACGCCAAAAACATTCAGTACTTCGGCGCC	CSARAQGYAKNIQYF	In	VDJ	1	30	0.0027958993476234857	0.0032230339492909325	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	4	3	1	2	4	26	39	46	41	50		TCRBV20-01,TCRBV20-or09_02												CSARAQGYAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGCCCGCGCGGGGGATACGCAGTATTTTGGCCCA	CSASARAGDTQYF	In	VDJ	1	30	0.0027958993476234857	0.0032230339492909325	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	3	6	7	0	26	37	-1	44	50		TCRBV20-01,TCRBV20-or09_02												CSASARAGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCATAAAGTTGGAGGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	0.0027958993476234857		41				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	2	7	8	0	18	35	-1	43	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGAGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSLAGGSTDTQYF	In	VDJ	1	30	0.0027958993476234857	0.0032230339492909325	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	9	0	0	0	0	18	-1	-1	35	42	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAGGSTDTQYF+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGGGACAGGGGCTGAACGAGCAGTACTTCGGGCCG	CSARDGGQGLNEQYF	In	VDJ	1	31	0.0028890959925442685	0.0033304684142672967	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	2	5	3	4	26	40	53	43	57		TCRBV20-01,TCRBV20-or09_02												CSARDGGQGLNEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCCCCGGGACAGGGGGCGCCTACGAGCAGTACTTCGGGCCG	CASSPGTGGAYEQYF	In	VDJ	1	32	0.0029822926374650513	0.0034379028792436614	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	0	2	4	1	24	35	51	39	52	TCRBV06,TCRBV10													CASSPGTGGAYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAATTGGGACCCCTTCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	34	0.003168685927306617		55	TCRBV03						TCRBJ02	TCRBJ02-06	01	5	0	7	5	4	14	26	38	47	42	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-06	TCRBV03		TCRBJ02-06*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGCCCCCTTCCCGGGAGTAGGCACAGATACGCAGTATTTTGGCCCA	CSAREAPFPGVGTDTQYF	In	VDJ	1	34	0.003168685927306617	0.00365277180919639	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	8	2	1	11	3	26	40	57	51	60		TCRBV20-01,TCRBV20-or09_02												CSAREAPFPGVGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCGGAGGGGACAGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	34	0.003168685927306617		43				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	4	1	4	0	18	30	-1	34	42	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGAGAAGTCCGGGACAGGGAAGGGGGTTGCGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	34	0.003168685927306617		62	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	3	3	7	12	18	35	51	42	63	TCRBV05,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTCGACCCCCCCCTAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	35	0.0032618825722274		52	TCRBV03						TCRBJ02	TCRBJ02-02	01	0	2	7	2	3	8	26	43	49	46	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCTCCCCCGACTTATAACTATGGCTACACCTTCGGTTCG	CASSPPPTYNYGYTF	In	VDJ	1	35	0.0032618825722274	0.0037602062741727547	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	2	10	1	8	2	18	30	42	38	44	TCRBV07,TCRBV11					01,02								CASSPPPTYNYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGTAGGGGGCTTAAATGAGCAGTTCTTCGGGCCA	CASSLVGGLNEQFF	In	VDJ	1	35	0.0032618825722274	0.0037602062741727547	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	5	0	7	1	3	18	34	42	35	45	TCRBV07,TCRBV11													CASSLVGGLNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAGAGAGTGGCAGCACAGATACGCAGTATTTTGGCCCA	CSARGESGSTDTQYF	In	VDJ	1	36	0.0033550792171481826	0.003867640739149119	45	TCRBV20						TCRBJ02	TCRBJ02-03	01	1	9	0	0	8	0	26	39	-1	47	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGESGSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGTAGCGGGGGCCAGCACAGATACGCAGTATTTTGGCCCA	CASSVVAGASTDTQYF	In	VDJ	1	36	0.0033550792171481826	0.003867640739149119	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	5	2	0	4	2	24	36	49	40	51	TCRBV09,TCRBV21													CASSVVAGASTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCTGACGTCGAGAGCGGGAGAGATTAGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	37	0.0034482758620689655		50	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	6	2	6	11	7	23	34	53	45	60	TCRBV06,TCRBV10													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACCTGGGGAGGAGCTCCTACGAGCAGTACTTCGGGCCG	CAISDLGRSSYEQYF	In	VDJ	1	37	0.0034482758620689655	0.003975075204125484	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	9	1	0	6	2	23	35	47	41	49	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												CAISDLGRSSYEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGTTACAGGGTGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	38	0.0035414725069897483		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	3	3	2	4	1	26	39	49	43	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGCCTTATGCGGGGGAATGAGCAGTTCTTCGGGCCA	CASSLMRGNEQFF	In	VDJ	1	38	0.0035414725069897483	0.0040825096691018475	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	2	7	6	0	23	34	-1	40	47	TCRBV02,TCRBV12													CASSLMRGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AACCAGACMKCTCTKTACTTCTGTGCCAGCAGGACCTCCTAGCGGGGGGGCCAGTCCGGCTAGGACAATGAGCAGTTCTTCGGGCCA	CASRTS*RGGQSG*DNEQFF	Stop	VDJ	1	39	0.003634669151910531		60	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	4	0	5	6	14	21	32	50	38	64	TCRBV24,TCRBV27													CASRTS*RGGQSG*DNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTATTATGGACAGGCTACAATGAGCAGTTCTTCGGGCCA	CASSVLWTGYNEQFF	In	VDJ	1	39	0.003634669151910531	0.004189944134078212	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	4	3	7	0	24	36	-1	43	50	TCRBV09,TCRBV21													CASSVLWTGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCTCGAGCTAATGTCTCGCAACAATGAGCAGTTCTTCGGGCCA	CASSLELMSRNNEQFF	In	VDJ	1	39	0.003634669151910531	0.004189944134078212	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	9	5	6	10	23	35	44	41	54	TCRBV09,TCRBV12					01,02								CASSLELMSRNNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAACCCTAACAGGGATCGAAAGACCCAGTACTTCGGGCCA	CSARNPNRDRKTQYF	In	VDJ	1	40	0.003727865796831314	0.004297378599054577	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	3	6	8	6	26	37	51	45	57		TCRBV20-01,TCRBV20-or09_02												CSARNPNRDRKTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGGGTCTAGGGGCGTCCGGGGAGCTGTTTTTTGGAGAA	CATRGLGASGELFF	In	VDJ	1	40	0.003727865796831314	0.004297378599054577	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	5	2	6	6	3	24	35	46	41	49		TCRBV24-01,TCRBV24-or09_02												CATRGLGASGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGCCCCGGTCCTGATCCCGAATATGGCTACACCTTCGGTTCG	CSARGPGPDPEYGYTF	In	VDJ	1	41	0.0038210624417520968	0.004404813064030941	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	8	0	5	0	18	26	-1	41	37	59		TCRBV20-01,TCRBV20-or09_02												CSARGPGPDPEYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTGCGATGACCCAGCAGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	41	0.0038210624417520968		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	4	4	13	6	24	35	52	48	58	TCRBV12,TCRBV21													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGGGCGGGCAGCACTGAAGCTTTCTTTGGACAA	CSAWAGSTEAFF	In	VDJ	1	42	0.00391425908667288	0.0045122475290073055	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	4	4	3	3	26	35	43	38	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSAWAGSTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGCTGACTGAAGCTTTCTTTGGACAA	CASSQALTEAFF	In	VDJ	1	43	0.004007455731593662	0.00461968199398367	36	TCRBV03						TCRBJ01	TCRBJ01-01	01	1	10	0	5	1	2	26	42	45	43	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQALTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGTATCCCATCCCATGCAAGATACGCAGTATTTTGGCCCA	CASSVSHPMQDTQYF	In	VDJ	1	45	0.004193849021435228	0.004834550923936399	45	TCRBV03						TCRBJ02	TCRBJ02-03	01	5	4	6	5	6	9	26	38	46	44	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVSHPMQDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGGACTAGCGGGATATGATGAGCAGTTCTTCGGGCCA	CATSDLGLAGYDEQFF	In	VDJ	1	46	0.004287045666356011	0.004941985388912763	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	1	3	8	0	4	24	-1	54	42	58		TCRBV24-01,TCRBV24-or09_02												CATSDLGLAGYDEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGACGAATCCCATTTCAGGCTGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	47	0.004380242311276794		53	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	4	5	14	3	26	40	58	54	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGTTACACTTCCTCGGACAGATTCTCCTACGAGCAGTACTTCGGGCCG	CASSYTSSDRFSYEQYF	In	VDJ	1	47	0.004380242311276794	0.005049419853889127	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	5	0	8	3	23	38	52	46	55	TCRBV06,TCRBV10													CASSYTSSDRFSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTATAAAACCCGGAGGACTCCCGAAAGTTTGGGAAGCTTTCTTTGGACAA		Out	VDJ	1	47	0.004380242311276794		56	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	1	10	8	11	13	18	33	49	44	62	TCRBV07,TCRBV11					01,02								X+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGTTTATTAACTAGCGGGAGTGGGCATGAGCAGTTCTTCGGGCCA	XASSLLTSGSGHEQFF	In	VDJ	1	48	0.004473438956197577	0.005156854318865492	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	3	2	8	2	5	25	41	54	43	59	TCRBV26,TCRBV28													XASSLLTSGSGHEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCGGCAGGTCCTACACCATCTATGGCTACACCTTCGGTTCG	CSAPGRSYTIYGYTF	In	VDJ	1	50	0.004659832246039142	0.0053717232488182205	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	4	4	6	11	26	34	44	40	55		TCRBV20-01,TCRBV20-or09_02												CSAPGRSYTIYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTAGCACACCGTACGAGCAGTACTTCGGGCCG	CSVSTPYEQYF	In	VDJ	1	50	0.004659832246039142	0.0053717232488182205	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	6	4	1	3	26	37	41	38	44		TCRBV20-01,TCRBV20-or09_02												CSVSTPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCARCCAGACCTMTCTGTACYWCTGTGCCAGCAGTTTTCCGACTAGCGGGAGGGCCCCGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSFPTSGRAPAYNEQFF	In	VDJ	1	51	0.004753028890959925	0.005479157713794585	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	2	0	2	7	6	22	32	53	39	59	TCRBV08,TCRBV27													CASSFPTSGRAPAYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAAGGACAGGGCCACTGAAGCTTTCTTTGGACAA	CASSEKDRATEAFF	In	VDJ	1	53	0.004939422180801492	0.005694026643747314	42	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	3	4	2	1	23	38	48	40	49		TCRBV06-01,TCRBV06-08												CASSEKDRATEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD01-01*01	TCRBJ01-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCGTACAGTGAACCAAGAGACCCAGTACTTCGGGCCA	XASSRTVNQETQYF	In	VDJ	1	53	0.004939422180801492	0.005694026643747314	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	5	0	3	3	22	34	41	37	44	TCRBV04,TCRBV07,TCRBV17													XASSRTVNQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGCCACTAGTAGGCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	58	0.005405405405405406		44	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	3	8	4	3	5	24	38	46	41	51		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTGGGACCACCTTATACGCAGTATTTTGGCCCA	CASSQDLGPPYTQYF	In	VDJ	1	61	0.005684995340167754	0.00655350236355823	45	TCRBV03						TCRBJ02	TCRBJ02-03	01	0	0	7	7	3	6	26	43	51	46	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDLGPPYTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCCTAGGAGCTAAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLLGAKNTGELFF	In	VDJ	1	61	0.005684995340167754	0.00655350236355823	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	4	8	1	2	7	26	39	45	41	52		TCRBV03-01,TCRBV03-02				01,02								CASSLLGAKNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGGGACTAGCGGGTATAATGACGCAGTATTTTGGCCCA	CSARDPGLAGIMTQYF	In	VDJ	1	64	0.005964585274930103	0.006875805758487323	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	4	9	3	7	26	40	55	43	62		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDPGLAGIMTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGAGGCGTAGAGGGGGGAGATTACAATGAGCAGTTCTTCGGGCCA	CASRGVEGGDYNEQFF	In	VDJ	1	66	0.006150978564771668	0.007090674688440051	48	TCRBV03						TCRBJ02	TCRBJ02-01	01	6	5	1	4	8	5	26	37	51	45	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGVEGGDYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCCCAGATCTGGGTGAAAAACTGTTTTTTGGCAGT	CSARAPDLGEKLFF	In	VDJ	1	70	0.0065237651444548	0.007520412548345509	42	TCRBV20						TCRBJ01	TCRBJ01-04	01	1	0	9	7	10	0	26	39	-1	49	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARAPDLGEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACGCTCTTTAGGGGACGGGAGCAGTTCTTCGGGCCA	CSATLFRGREQFF	In	VDJ	1	74	0.006896551724137931	0.007950150408250967	39	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	0	7	10	12	2	26	34	51	46	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATLFRGREQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGGGTAGCTCCCATGCAAAGAAAAAACATTCAGTACTTCGGCGCC	CASSRVAPMQRKNIQYF	In	VDJ	1	81	0.007548928238583411	0.008702191663085519	51	TCRBV03						TCRBJ02	TCRBJ02-04	01	5	5	3	4	0	17	26	-1	42	38	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRVAPMQRKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03		TCRBJ02-04*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTAAGGGGGGGCAAGAGACCCAGTACTTCGGGCCA	CSARVKGGQETQYF	In	VDJ	1	82	0.0076421248835041936	0.008809626128061882	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	9	0	2	4	0	26	39	-1	43	50		TCRBV20-01,TCRBV20-or09_02												CSARVKGGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTGCCTGGGACGGACCCTAAATCATATGGCTACACCTTCGGTTCG		Out	VDJ	1	82	0.0076421248835041936		50	unresolved						TCRBJ01	TCRBJ01-02	01	4	0	7	5	4	13	18	31	40	35	53	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTTACAGTTTTACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSFTVLQSRANVLTF	In	VDJ	2	113	0.010531220876048462	0.012140094542329179	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	5	5	3	12	26	38	45	41	57		TCRBV03-01,TCRBV03-02												CASSFTVLQSRANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCCCAGTCCGGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSPQSGTYNEQFF	In	VDJ	3	175	0.016309412861136997	0.018801031370863773	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	3	2	9	0	26	37	-1	46	51		TCRBV03-01,TCRBV03-02												CASSPQSGTYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCACTAGCGGGACTTACAATGAGCAGTTCTTCGGGCCA	CASSPTSGTYNEQFF	In	VDJ	3	189	0.01761416589002796	0.020305113880532875	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	3	3	4	2	2	26	39	51	41	53		TCRBV03-01,TCRBV03-02												CASSPTSGTYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTCAGACAGGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSPQTGTYNEQFF	In	VDJ	7	452	0.04212488350419385	0.048560378169316715	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	3	2	4	1	26	39	50	43	51		TCRBV03-01,TCRBV03-02												CASSPQTGTYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAACTAGCGGGGTATACAATGAGCAGTTCTTCGGGCCA	CASSPTSGVYNEQFF	In	VDJ	21	1361	0.12684063373718546	0.14621830683283196	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	3	3	4	2	2	26	39	51	41	53		TCRBV03-01,TCRBV03-02												CASSPTSGVYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGACACTCCCCCGGGACAGGGAAACCGGGGAGTTGTTTTTTGGAGAA		Out	VDJ	1	21	0.00195712954333644		50	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	15	10	12	23	34	53	44	65		TCRBV06-08,TCRBV06-09												X+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGCGGGGGGTCTCGGTGAAAAACTGTTTTTTGGCAGT	CASSEAGGLGEKLFF	In	VDJ	1	23	0.0021435228331780055	0.0024709926944563817	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	6	1	7	2	6	26	38	49	40	55		TCRBV06-01,TCRBV06-07												CASSEAGGLGEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACCCAGATTCTCAGGGGAGAAATGAGCAGTTCTTCGGGCCA	CASSYPDSQGRNEQFF	In	VDJ	1	30	0.0027958993476234857	0.0032230339492909325	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	2	7	9	3	23	38	53	47	56		TCRBV06-07,TCRBV06-08												CASSYPDSQGRNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GGGGGACTYRGCYRTGTATCKCTGTGCCAGCAGCTTAGAAGACGGGACCTACGAGCAGTACTTCGGGCCG	CASSLEDGTYEQYF	In	VDJ	1	30	0.0027958993476234857	0.0032230339492909325	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	8	3	2	4	0	19	35	-1	39	44		TCRBV07-01,TCRBV07-07												CASSLEDGTYEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCACCGCGGCCGGGACACATAATTCACCCCTCCACTTTGGGAAC	CASTAAGTHNSPLHF	In	VDJ	1	42	0.00391425908667288	0.0045122475290073055	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	0	6	5	8	1	26	36	50	44	51														CASTAAGTHNSPLHF+TCRBV06-07+TCRBJ01-06	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-06*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCGCCCCCTCTGGAAACACCATATATTTTGGAGAG	CASSAPSGNTIYF	In	VDJ	2	98	0.009133271202236719	0.010528577567683713	39	TCRBV16	TCRBV16-01					TCRBJ01	TCRBJ01-03	01	5	10	0	0	0	3	29	-1	43	41	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAPSGNTIYF+TCRBV16-01+TCRBJ01-03	TCRBV16-01		TCRBJ01-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCATGGAACAAACACCAATGAAAAACTGTTTTTTGGCAGT	CASSHGTNTNEKLFF	In	VDJ	3	169	0.015750232991612302	0.018156424581005588	45	TCRBV16	TCRBV16-01					TCRBJ01	TCRBJ01-04	01	3	1	8	5	1	9	29	43	47	44	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHGTNTNEKLFF+TCRBV16-01+TCRBJ01-04	TCRBV16-01		TCRBJ01-04*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CACCAGCCAAACAGCTTTGTACTTCTGTCCTGGGAGAAAATGCCGAAGCGAGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	22	0.0020503261882572226		49	TCRBV22	TCRBV22-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	6	6	4	10	8	25	36	50	46	58						01,02								X+TCRBV22-01+TCRBJ01-02	TCRBV22-01*01	TCRBD02-01	TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CACCAGCCAAACAGCTTTGTACTTCTGTCCTGGGAGCTAAGTGGAAGCGAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	27	0.002516309412861137		53	TCRBV22	TCRBV22-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	4	6	6	5	8	9	25	37	49	45	58						01,02								X+TCRBV22-01+TCRBJ02-06	TCRBV22-01*01	TCRBD02-01	TCRBJ02-06*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CACCAGCCAAACAGCTTTGTACTTCTGTCCTGGGAGCCACTTTCAGCGAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	42	0.00391425908667288		52	TCRBV22	TCRBV22-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	4	6	6	5	7	9	25	37	48	44	57						01,02								X+TCRBV22-01+TCRBJ02-06	TCRBV22-01*01	TCRBD02-01	TCRBJ02-06*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATTTGGGGGGATTGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQDLGGLDSNQPQHF	In	VDJ	1	21	0.00195712954333644	0.0022561237645036527	54	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	9	1	0	3	6	23	40	49	43	55													Vb 7.1	CASSQDLGGLDSNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD02-01*01	TCRBJ01-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCCCGAGTGCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	42	0.00391425908667288		49	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	11	2	0	4	4	23	40	47	44	51													Vb 7.1	X+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGAGGAGGGACGGGAGACCCAGTACTTCGGGCCA	XASSQEEGRETQYF	In	VDJ	1	56	0.00521901211556384	0.006016330038676407	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	10	0	5	0	4	23	-1	46	40	50													Vb 7.1	XASSQEEGRETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGGAGGAGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSGRRSSYNEQFF	In	VDJ	1	34	0.003168685927306617	0.00365277180919639	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	1	0	0	5	18	-1	36	30	41														CATSGRRSSYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAAGTGGCTTCGGGGGCTACACCTTCGGTTCG	CASSLGSGFGGYTF	In	VDJ	1	21	0.00195712954333644	0.0022561237645036527	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	8	4	8	10	0	18	34	-1	44	48						01,02								CASSLGSGFGGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTAACCGACAGGGGCGACTTAATTTTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	0.0022367194780987883		53	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	2	3	4	12	18	31	43	35	55														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTAGTCACCGGGACAAGTCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	25	0.002329916123019571		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	6	1	7	4	18	31	44	38	48														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAGGACAGGGTTTCTATAATTCACCCCTCCACTTTGGGAAC	CASSRGQGFYNSPLHF	In	VDJ	1	26	0.002423112767940354	0.002793296089385475	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	3	3	3	3	18	30	41	33	44														CASSRGQGFYNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCGGGCCAGGGGGACTATGGCTACACCTTCGGTTCG	CASSSPGQGDYGYTF	In	VDJ	1	27	0.002516309412861137	0.0029007305543618392	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	1	3	8	0	18	31	-1	39	46														CASSSPGQGDYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCGGCGGGACCCAATACGAGCAGTACTTCGGGCCG	CASSLAGGTQYEQYF	In	VDJ	1	30	0.0027958993476234857	0.0032230339492909325	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	3	4	5	5	18	32	43	37	48														CASSLAGGTQYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACCCCGGATGGAAGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASNPGWKAGANVLTF	In	VDJ	1	34	0.003168685927306617	0.00365277180919639	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	7	1	8	2	5	7	18	28	36	33	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNPGWKAGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAGGGGGGTCGTATGAGCAGTTCTTCGGGCCA	CASSLVGGSYEQFF	In	VDJ	1	44	0.004100652376514445	0.004727116458960034	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	1	5	1	8	1	5	18	34	41	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGGSYEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGATAGGTGGGGCCAAGGGGCCCTACGAGCAGTACTTCGGGCCG	CASSQIGGAKGPYEQYF	In	VDJ	1	50	0.004659832246039142	0.0053717232488182205	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	2	2	16	1	18	30	51	46	52														CASSQIGGAKGPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCGCTCGACGCGCAAACAGGGGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	52	0.004846225535880708		56	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	2	3	17	0	18	30	-1	47	54														X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCGACAGTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSADSYSNQPQHF	In	VDJ	1	52	0.004846225535880708	0.00558659217877095	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	5	0	3	3	18	30	38	33	41														CASSADSYSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTATTCCCGCGGGGGTGCCCTCTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	81	0.007548928238583411		49	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	4	7	2	7	6	7	18	31	44	37	51														X+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-04*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAGGATCCCAGGGGGACGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGGSQGDVSGANVLTF	In	VDJ	1	81	0.007548928238583411	0.008702191663085519	60	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	4	1	0	8	4	18	34	49	42	53														CASSLGGSQGDVSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGGAGACTAGCGGGGAGGCCGCGATACGCAGTATTTTGGCCCA		Out	VDJ	1	25	0.002329916123019571		43	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	2	3	6	5	7	26	31	47	36	54														X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGACAGGGGAAACACCATATATTTTGGAGAG	CASGLDRGNTIYF	In	VDJ	2	106	0.009878844361602983	0.011388053287494627	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	3	4	4	0	0	26	-1	-1	42	47														CASGLDRGNTIYF+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGATGGGGGACGGAGCAGACGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASGLMGDGADGAKNIQYF	In	VDJ	2	124	0.011556383970177074	0.013321873657069187	57	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-04	01	2	0	7	1	4	12	24	39	48	43	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLMGDGADGAKNIQYF+TCRBV12-05+TCRBJ02-04	TCRBV12-05*01		TCRBJ02-04*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTGGGCCTCCCCGGGGGCTGGAGGAGCAGTACTTCGGGCCG	CAGPPRGLEEQYF	In	VDJ	3	221	0.02059645852749301	0.023743016759776536	39	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-07	01	11	6	0	7	10	5	26	32	48	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAGPPRGLEEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01		TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGTCAGCGAACTACGAGCAGTACTTCGGGCCG	CASSQSSANYEQYF	In	VDJ	1	42	0.00391425908667288	0.0045122475290073055	42	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	6	6	3	3	2	20	37	44	40	46						01,02								CASSQSSANYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGGCCCCGATAACTATGGCTACACCTTCGGTTCG	CASSYGGPDNYGYTF	In	VDJ	1	20	0.001863932898415657	0.0021486892995272885	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	6	0	1	0	5	23	-1	44	38	49														CASSYGGPDNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGGGTCCGCGGGCTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	21	0.00195712954333644		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	7	4	0	7	3	23	33	45	40	48						01,02								X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCTGGGACAGGGTCCTAGCCGGGCATTTTGGTGAT	CASSYSWDRVLAGHF	In	VDJ	1	22	0.0020503261882572226	0.002363558229480017	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	3	15	2	10	23	40	51	42	61														CASSYSWDRVLAGHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATATATGGGAGGGGAACTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	22	0.0020503261882572226		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	9	0	9	5	4	23	37	49	42	53														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCAGCCGGATCACTAGTGAATGAGCAGTTCTTCGGGCCA	CASSAAGSLVNEQFF	In	VDJ	1	23	0.0021435228331780055	0.0024709926944563817	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	8	7	11	2	23	35	51	46	53						01,02								CASSAAGSLVNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAGGGGGGACTGCTTCCAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	28	0.00260950605778192		49	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	5	5	1	2	2	11	23	35	43	37	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCGACAGGGGGAAGTTCTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPTGGSSSNQPQHF	In	VDJ	1	37	0.0034482758620689655	0.003975075204125484	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	1	0	3	6	23	34	46	37	52														CASSPTGGSSSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCGGGCCTATAGACCAGTATTTTGGCCCA	CASSFGPIDQYF	In	VDJ	1	37	0.0034482758620689655	0.003975075204125484	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	4	8	0	12	2	8	23	36	42	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGPIDQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACTCAGACTAGCGGGCTTTGATAATGAGCAGTTCTTCGGGCCA	CASRLRLAGFDNEQFF	In	VDJ	1	51	0.004753028890959925	0.005479157713794585	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	4	7	5	7	23	34	49	39	56						01,02								CASRLRLAGFDNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCCGGGACAGGGACTTTAAAGGGGTATGGCTACACCTTCGGTTCG	CASSSGTGTLKGYGYTF	In	VDJ	1	51	0.004753028890959925	0.005479157713794585	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	5	4	12	23	34	47	38	59														CASSSGTGTLKGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCCAGGGGCGACAACAAAAACATTCAGTACTTCGGCGCC	CASSSRGDNKNIQYF	In	VDJ	1	52	0.004846225535880708	0.00558659217877095	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	4	2	3	3	6	23	34	43	37	49														CASSSRGDNKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGAGGGGGCGTTGTTAGAGAGACTCAGTACTTCGGGCCA	CASSYRGGVVRETQYF	In	VDJ	1	52	0.004846225535880708	0.00558659217877095	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	5	0	11	2	15	23	38	47	40	62														CASSYRGGVVRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATTAGCGGGGGGGCGGTCAGAGACCCAGTACTTCGGGCCA	CASRLAGGRSETQYF	In	VDJ	1	66	0.006150978564771668	0.007090674688440051	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	5	0	4	2	5	23	34	47	36	52														CASRLAGGRSETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGGAGCAGGTGGGCAGCTTTCTTTGGACAA	CASSYRSRWAAFF	In	VDJ	1	66	0.006150978564771668	0.007090674688440051	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	4	4	10	5	5	23	38	47	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRSRWAAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAACGGGCATCCTAATGAAAAACTGTTTTTTGGCAGT	CASSYNGHPNEKLFF	In	VDJ	1	78	0.007269338303821062	0.008379888268156424	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	2	8	0	3	3	3	23	38	45	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYNGHPNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCACGGGGGCGCAAAGAGACCCAGTACTTCGGGCCA	CASSYSRGRKETQYF	In	VDJ	1	83	0.007735321528424976	0.008917060593038246	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	0	6	0	3	2	3	23	40	48	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSRGRKETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGTCTCGCGGCTGCCTTTCACTGAAGCTTTCTTTGGACAA	CASSVSRLPFTEAFF	In	VDJ	5	329	0.030661696178937558	0.03534593897722389	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	7	5	4	6	8	23	34	44	40	52						01,02								CASSVSRLPFTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGGAGAGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	24	0.0022367194780987883		38	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	6	1	7	0	4	24	-1	43	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCCCCCTAGCGGGAGCAACCAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	27	0.002516309412861137		52	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	4	2	4	4	5	24	41	55	45	60													Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCCTAGGCCCCTTCCCGGGTCGTACTTCGGCGCC		Out	VDJ	1	28	0.00260950605778192		40	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	6	4	8	15	3	15	24	35	42	38	57						01,02							Vb 18	X+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD02-01	TCRBJ02-04*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGACAGGGTTCCTACGAGCAGTACTTCGGGCCG	CASSPGQGSYEQYF	In	VDJ	1	50	0.004659832246039142	0.0053717232488182205	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	1	0	1	24	-1	47	38	48													Vb 18	CASSPGQGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGAAGGGGCGACACTGAAGCTTTCTTTGGACAA	CASSRRGDTEAFF	In	VDJ	1	56	0.00521901211556384	0.006016330038676407	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	5	2	3	2	2	24	37	44	39	46													Vb 18	CASSRRGDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCTCGGGGGGCCGAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGGRDTGELFF	In	VDJ	2	105	0.0097856477166822	0.011280618822518265	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	8	1	3	2	5	24	35	44	37	49													Vb 18	CASSSGGRDTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-02*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGCGGTCACCTCAATGAACACTGAAGCTTTCTTTGGACAA	CASSPAVTSMNTEAFF	In	VDJ	2	116	0.010810810810810811	0.012462397937258273	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	7	5	0	1	9	24	38	43	39	52						01,02							Vb 18	CASSPAVTSMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	8089A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				230	199	29	0	0	181	143	37	1	0	10730	9308	1383	39	0	0.111332513	6.36274481	0.0982790813	6.76276779				1095	0.149120003	0.1462183	0.126840636	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:51	Age (Range):45-65 Years (Late Adulthood),Age:55 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1443,pfs censored status:pfs censored status 0,progression free survival (days):progression free survival (days) 1495,type of chemo:carbo/taxol	0.8652173677216177	MSKCC- Snyder- P01-02		163.0	
